JP2023532003A5 - - Google Patents

Info

Publication number
JP2023532003A5
JP2023532003A5 JP2022579890A JP2022579890A JP2023532003A5 JP 2023532003 A5 JP2023532003 A5 JP 2023532003A5 JP 2022579890 A JP2022579890 A JP 2022579890A JP 2022579890 A JP2022579890 A JP 2022579890A JP 2023532003 A5 JP2023532003 A5 JP 2023532003A5
Authority
JP
Japan
Prior art keywords
sdab
saponin
xyl
rha
fuc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022579890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532003A (ja
Filing date
Publication date
Priority claimed from PCT/EP2020/069340 external-priority patent/WO2021259507A1/en
Application filed filed Critical
Priority claimed from PCT/EP2021/067030 external-priority patent/WO2021259944A1/en
Publication of JP2023532003A publication Critical patent/JP2023532003A/ja
Publication of JP2023532003A5 publication Critical patent/JP2023532003A5/ja
Pending legal-status Critical Current

Links

JP2022579890A 2020-06-24 2021-06-22 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用 Pending JP2023532003A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NL2025900 2020-06-24
NL2025900 2020-06-24
EPPCT/EP2020/069340 2020-07-09
PCT/EP2020/069340 WO2021259507A1 (en) 2020-06-24 2020-07-09 Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition
PCT/EP2021/067030 WO2021259944A1 (en) 2020-06-24 2021-06-22 Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition

Publications (2)

Publication Number Publication Date
JP2023532003A JP2023532003A (ja) 2023-07-26
JP2023532003A5 true JP2023532003A5 (cg-RX-API-DMAC10.html) 2024-07-01

Family

ID=76502738

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022579892A Active JP7652807B2 (ja) 2020-06-24 2020-07-09 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用
JP2022579890A Pending JP2023532003A (ja) 2020-06-24 2021-06-22 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用
JP2025041685A Pending JP2025090796A (ja) 2020-06-24 2025-03-14 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022579892A Active JP7652807B2 (ja) 2020-06-24 2020-07-09 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025041685A Pending JP2025090796A (ja) 2020-06-24 2025-03-14 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用

Country Status (10)

Country Link
US (2) US20230277680A1 (cg-RX-API-DMAC10.html)
EP (3) EP4117731A1 (cg-RX-API-DMAC10.html)
JP (3) JP7652807B2 (cg-RX-API-DMAC10.html)
KR (2) KR20230043116A (cg-RX-API-DMAC10.html)
CN (2) CN116322782A (cg-RX-API-DMAC10.html)
AU (2) AU2020454676A1 (cg-RX-API-DMAC10.html)
CA (2) CA3182793A1 (cg-RX-API-DMAC10.html)
IL (2) IL299352A (cg-RX-API-DMAC10.html)
MX (1) MX2023000031A (cg-RX-API-DMAC10.html)
WO (1) WO2021259944A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023121447A1 (en) * 2021-12-22 2023-06-29 Sapreme Technologies B.V. Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition
WO2026119464A1 (en) * 2024-12-03 2026-06-11 Sapreme Technologies B.V. Treatment for cns-related disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ500779A (en) * 1997-05-20 2001-06-29 Galenica Pharmaceuticals Inc Triterpene saponin analogs having adjuvant and immunostimulatory activity
CA2522213A1 (en) * 2003-04-08 2004-10-28 Dante J. Marciani Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
ES2395818T3 (es) 2004-07-13 2013-02-15 Charite - Universitatsmedizin Berlin Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina
US20090252681A1 (en) 2005-10-11 2009-10-08 Ablynx N.V. Nanobodies and Polypeptides Against EGFR and IGF-IR
CA2706425A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
US9932403B2 (en) 2010-05-20 2018-04-03 Ablynx Nv Biological materials related to HER3
WO2012042026A1 (en) 2010-09-30 2012-04-05 Ablynx Nv Biological materials related to c-met
US20160251440A1 (en) 2013-09-26 2016-09-01 Ablynx N.V. Bispecific nanobodies
TWI731535B (zh) * 2014-03-21 2021-06-21 美商艾伯維有限公司 抗-egfr抗體及抗體藥物結合物
TWI787796B (zh) * 2015-05-04 2022-12-21 美商Cytomx生物製藥公司 抗cd71抗體類、可活化之抗cd71抗體類及使用彼等之方法
KR102775461B1 (ko) * 2016-04-01 2025-02-28 어비디티 바이오사이언시스 인크. 핵산-폴리펩타이드 조성물 및 이의 용도
WO2020052543A1 (en) * 2018-09-10 2020-03-19 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies against cd33 and constructs thereof
US20220023433A1 (en) * 2018-12-21 2022-01-27 Sapreme Technologies B.V. Saponin Conjugates
EP3908608A1 (en) * 2019-01-09 2021-11-17 Vect-Horus Transferrin receptor-binding molecules, conjugates thereof and their uses

Similar Documents

Publication Publication Date Title
JP2022516045A5 (cg-RX-API-DMAC10.html)
JP2023532040A5 (cg-RX-API-DMAC10.html)
JP7652808B2 (ja) Vhhを含むadc又はaocと、サポニン又はリガンド-サポニンコンジュゲートとを含む組み合わせ
WO2021259507A1 (en) Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition
EP4171640A1 (en) Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereof
JP2025090796A (ja) 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用
JP2023532679A (ja) 抗体-薬物コンジュゲート及び抗体-サポニンコンジュゲートの組合せ
US20250295800A1 (en) Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition
HK40132001A (en) Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition
HK40130827A (en) Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugate
RU2021121380A (ru) Улучшенная клеточно-таргетная связующая молекула
NZ778372A (en) Biologically active cluster of molecules
NZ778372B2 (en) Biologically active cluster of molecules